BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 18973455)

  • 1. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies.
    Patel G; Huprikar S; Factor SH; Jenkins SG; Calfee DP
    Infect Control Hosp Epidemiol; 2008 Dec; 29(12):1099-106. PubMed ID: 18973455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia.
    Borer A; Saidel-Odes L; Riesenberg K; Eskira S; Peled N; Nativ R; Schlaeffer F; Sherf M
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):972-6. PubMed ID: 19712030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection.
    Ben-David D; Maor Y; Keller N; Regev-Yochay G; Tal I; Shachar D; Zlotkin A; Smollan G; Rahav G
    Infect Control Hosp Epidemiol; 2010 Jun; 31(6):620-6. PubMed ID: 20370465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
    Hussein K; Raz-Pasteur A; Finkelstein R; Neuberger A; Shachor-Meyouhas Y; Oren I; Kassis I
    J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection.
    Correa L; Martino MD; Siqueira I; Pasternak J; Gales AC; Silva CV; Camargo TZ; Scherer PF; Marra AR
    BMC Infect Dis; 2013 Feb; 13():80. PubMed ID: 23398691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
    Ny P; Nieberg P; Wong-Beringer A
    Am J Infect Control; 2015 Oct; 43(10):1076-80. PubMed ID: 26190386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study.
    Kofteridis DP; Valachis A; Dimopoulou D; Maraki S; Christidou A; Mantadakis E; Samonis G
    J Infect Chemother; 2014 May; 20(5):293-7. PubMed ID: 24703709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant.
    Gregory CJ; Llata E; Stine N; Gould C; Santiago LM; Vazquez GJ; Robledo IE; Srinivasan A; Goering RV; Tomashek KM
    Infect Control Hosp Epidemiol; 2010 May; 31(5):476-84. PubMed ID: 20334553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
    Wu D; Cai J; Liu J
    South Med J; 2011 Feb; 104(2):106-10. PubMed ID: 21258230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study.
    Simkins J; Muggia V; Cohen HW; Minamoto GY
    Transpl Infect Dis; 2014 Oct; 16(5):775-82. PubMed ID: 25092500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections.
    Ben-David D; Kordevani R; Keller N; Tal I; Marzel A; Gal-Mor O; Maor Y; Rahav G
    Clin Microbiol Infect; 2012 Jan; 18(1):54-60. PubMed ID: 21722257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents.
    Mills JP; Talati NJ; Alby K; Han JH
    Infect Control Hosp Epidemiol; 2016 Jan; 37(1):55-60. PubMed ID: 26455382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPIDEMIOLOGY OF CARBAPENEM-RESISTANT KLEBSIELLA PNEUMONIAE IN INTENSIVE CARE UNITS OF MULTIPROFILE HOSPITALS IN TBILISI, GEORGIA.
    Tsereteli M; Sidamonidze K; Tsereteli D; Malania L; Vashakidze E
    Georgian Med News; 2018; (280-281):164-168. PubMed ID: 30204118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae.
    Kochar S; Sheard T; Sharma R; Hui A; Tolentino E; Allen G; Landman D; Bratu S; Augenbraun M; Quale J
    Infect Control Hosp Epidemiol; 2009 May; 30(5):447-52. PubMed ID: 19301985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae.
    Gonzalez-Padilla M; Torre-Cisneros J; Rivera-Espinar F; Pontes-Moreno A; López-Cerero L; Pascual A; Natera C; Rodríguez M; Salcedo I; Rodríguez-López F; Rivero A; Rodríguez-Baño J
    J Antimicrob Chemother; 2015 Mar; 70(3):905-13. PubMed ID: 25344809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients.
    Pouch SM; Kubin CJ; Satlin MJ; Tsapepas DS; Lee JR; Dube G; Pereira MR
    Transpl Infect Dis; 2015 Dec; 17(6):800-9. PubMed ID: 26341757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study.
    Falagas ME; Rafailidis PI; Kofteridis D; Virtzili S; Chelvatzoglou FC; Papaioannou V; Maraki S; Samonis G; Michalopoulos A
    J Antimicrob Chemother; 2007 Nov; 60(5):1124-30. PubMed ID: 17884829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.
    Hussein K; Sprecher H; Mashiach T; Oren I; Kassis I; Finkelstein R
    Infect Control Hosp Epidemiol; 2009 Jul; 30(7):666-71. PubMed ID: 19496647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.
    Jiao Y; Qin Y; Liu J; Li Q; Dong Y; Shang Y; Huang Y; Liu R
    Pathog Glob Health; 2015 Mar; 109(2):68-74. PubMed ID: 25707874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.